Src(Src激酶)
Src (proto-oncogene tyrosine-protein kinase) is a non-receptor protein tyrosine kinase family including 9 members and promotes survival, angiogenesis, proliferation and invasion pathways.
Products for Src
- Cat.No. 产品名称 Information
-
GC33181
T338C Src-IN-2
T338CSrc-IN-2是突变型c-Src激酶抑制剂,IC50值317nM,还能抑制T338C/V323A和T338C/V323S双突变Src活性,IC50值57和19nM。
- GC33168 T338C Src-IN-1 T338CSrc-IN-1是突变型c-SrcT338C高效抑制剂,IC50值111nM。对WTSrc活性弱10倍以上。
-
GC32992
7-Hydroxy-4-chromone (7-Hydroxychromone)
7-羟基色原酮,7-Hydroxychromone
7-Hydroxychromone is an inhibitor of Src kinase with IC50 of <300 μM. -
GC32875
AZM475271 (M475271)
M475271
An inhibitor of c-Src kinase -
GC32835
PP58
PP58是吡啶[2,3-d]嘧啶化合物,抑制PDGFR,FGFR和Src家族活性的IC50值在纳摩尔级。
- GC32825 eCF506 An inhibitor of Src kinases
- GC32797 AD80 AD80, a multikinase inhibitor, shows strong activity against human RET (c-RET), BRAF, S6K, and SRC but were much less active than either AD57 or AD58 against mTOR. The IC50 value for RET is 4 nM.
-
GC31701
RK-24466 (KIN 001-51)
KIN 001-51
A selective inhibitor of lymphocyte-specific protein tyrosine kinase -
GC19366
UM-164
DAS-DFGO-II
An inhibitor of Src and p38 MAPK kinases - GC18438 CGP 77675 An inhibitor of Src family kinases
-
GC17669
AMG-47A
4-甲基-3-[2-[[2-(4-吗啉基)乙基]氨基]-6-喹唑啉基]-N-[3-(三氟甲基)苯基]苯甲酰胺
A multi-kinase inhibitor - GC17500 SU6656 Inhibitor of Src kinases
-
GC13600
WH-4-023
Dual LCK/SRC inhibitor
An inhibitor of Lck and Src - GC17638 KB SRC 4 KB SRC 4 是一种有效的、高选择性的 c-Src 抑制剂,Ki 为 44 nM,Kd 为 86 nM,对 c-Abl 没有抑制作用,最高可达 125 μM; KB SRC 4 具有抗肿瘤活性。
-
GC10775
MLR 1023
托利咪酮,MLR-1023
An allosteric Lyn kinase activator - GC12958 ER 27319 maleate Syk激酶的选择性抑制剂
-
GC16957
Src I1
7-二甲氧基-N-(4-苯氧基苯基)-氨基喹唑啉,Src Kinase Inhibitor 1; Src-l1
A potent inhibitor of Src kinases - GC11526 N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide Phosphopeptide for binding to the src SH2 domain
- GC12746 N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu Phosphopeptide ligand for the src SH2 domain
- GC17137 pp60 c-src (521-533) (phosphorylated) Peptide corresponding to the pp60c-src carboxy terminal regulatory domain
-
GC13797
PP 3
4-氨基-1-苯基吡唑[3,4-D]嘧啶
A negative control for Src tyrosine kinase inhibitors - GC15211 Damnacanthal Damnacanthal 是一种从海巴戟根中分离出来的蒽醌。
-
GC15000
Herbimycin A
除莠霉素A
An inhibitor of tyrosine kinases and Hsp90 - GC10523 KX1-004 An inhibitor of Src-PTK
-
GC17789
A 419259 trihydrochloride
7-[反式-4-(4-甲基-1-哌嗪基)环己基]-5-(4-苯氧基苯基)-7H-吡咯并[2,3-D]嘧啶-4-胺三盐酸盐,RK 20449 trihydrochloride
An inhibitor of Src family kinases -
GC11696
1-NM-PP1
4-氨基1-叔丁基-3-(1'-萘甲基)吡唑并[3,4-D]嘧啶,PP1 Analog II
Inhibitor of modified 'analog-sensitive' kinases -
GC14292
Apatinib Mesylate
阿帕替尼
A selective VEGFR2 inhibitor
-
GC14007
DCC-2036 (Rebastinib)
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲,DCC-2036
An orally bioavailable tyrosine kinase inhibitor - GC11003 PP121 A potent dual inhibitor of tyrosine and phosphoinositide kinases
-
GC14288
KX2-391
5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺,KX2-391; KX-01
A Src kinase inhibitor -
GC13592
PD173955
6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮
A tyrosine kinase inhibitor -
GC12185
ZM 306416
CB 676475
A VEGF receptor kinase inhibitor -
GC14332
NVP-BHG712
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺,BHG712
A selective EphB4 kinase inhibitor -
GC10048
MNS
3,4-亚甲二氧-beta-硝基苯乙烯,NSC 170724; 5-(2-Nitrovinyl)benzodioxole
An inhibitor of Src, Syk, and platelet aggregation -
GC12172
1-Naphthyl PP1
4-氨基-1-叔丁基-3-(1'-萘基)吡唑并[3,4-D]嘧啶,1-NA-PP 1
Inhibitor of modified ‘analog-sensitive’ kinases -
GC14807
Fingolimod (FTY720) HCl
盐酸芬戈莫德; FTY720
芬戈莫德(FTY720)是一种免疫抑制剂,通常用于治疗多发性硬化症,也有抗癌作用,可以作为HDACi(组蛋白脱乙酰酶抑制剂)。 -
GC14396
Ponatinib (AP24534)
普纳替尼; AP24534
An inhibitor of native and mutant Bcr-Abl -
GC15197
Saracatinib (AZD0530)
塞卡替尼; AZD0530
A dual inhibitor of c-Src and Abl -
GC17473
Pelitinib (EKB-569)
培利替尼; EKB-569; WAY-EKB 569
An EGFR receptor tyrosine kinase inhibitor -
GC13410
Masitinib (AB1010)
马赛替尼; AB1010
An inhibitor of c-Kit -
GC13343
Bosutinib (SKI-606)
伯舒替尼,SKI-606
An inhibitor of Src and Abl kinases -
GC10344
PP 2 (AG 1879)
AGL 1879
A selective inhibitor of Src tyrosine kinases -
GC17990
PP 1
蛋白磷酸酯酶-1(抗原),AGL 1872; EI 275
Potent, selective Src family tyrosine kinase inhibitor -
GC13102
XL228
N4-(5-环丙基-1H-吡唑-3-基)-N2-[[3-异丙基-5-异恶唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺,XL-228;XL 228
A tyrosine kinase inhibitor -
GC11622
TG 100801
4-氯-3-[5-甲基-3-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-1,2,4-苯并三嗪-7-基]苯酚苯甲酸酯,TG100801;TG-100801
TG 100801 是一种前药,可通过在开发过程中的去酯化作用产生 TG 100572,以治疗年龄相关性黄斑变性。 TG 100572 是一种多靶点激酶抑制剂,可抑制受体酪氨酸激酶和 Src 激酶;对于 VEGFR1、VEGFR2、FGFR1、FGFR2、PDGFRβ、Fgr、Fyn、Hck、Lck、Lyn、Src、Yes , 分别。 -
GC13117
Lck Inhibitor
6-(2,6-二甲基苯基)-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-嘧啶并[5',4':5,6]嘧啶并[1,2-A]苯并咪唑-5(6H)-酮
A selective inhibitor of lymphocyte-specific protein tyrosine kinase -
GC10222
KX2-391 dihydrochloride
5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺盐酸盐,KX2-391 2HCl; KX2-391
A Src kinase inhibitor -
GC16519
ENMD-2076
6-(4-甲基-1-哌嗪基)-N-(5-甲基-1H-吡唑-3-基)-2-[(1E)-2-苯乙烯基]-4-嘧啶胺
A multi-kinase inhibitor - GC12145 ENMD-2076 L-(+)-Tartaric acid ENMD-2076 L-(+)-Tartaric acid 是一种多靶点激酶抑制剂,对 Aurora A、Flt3、KDR/VEGFR2、Flt4/VEGFR3、FGFR1 的 IC50 为 1.86、14、58.2、15.9、92.7、70.8、56.4 nM , FGFR2, Src, PDGFRα, 分别。
-
GC15568
Dasatinib (BMS-354825)
达沙替尼; BMS-354825
An inhibitor of Abl and Src